A novel assay for nicked, multi-chain free PSA enhances discrimination of prostate cancer cases from men with no cancer and PSA-levels of 2-10 ng/ml

被引:0
|
作者
Niemela, PM
Steuber, T
Huland, H
Lilja, H
Pettersson, K
机构
来源
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
1434
引用
收藏
页码:383 / 384
页数:2
相关论文
共 50 条
  • [21] Prostate cancer detetction rate at total PSA-levels below 2.5ng/ml: The utility of percent free PSA, meaningful %FPSA cutoffs and the clinical significance of prostate cancers detected
    Haese, Alexander
    Walz, Jochen
    Chun, Felix K. H.
    Schlomm, Thorsten
    Huland, Hartwig
    Graefen, Markus
    Gallina, Andrea
    Briganti, Alberto
    Rigatti, Patrizio
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 723 - 723
  • [22] Free/Total PSA Ratio: Predictive Value in Auguring Prostate Cancer Occurrence in African Men with Initial PSA Levels of 2.0 to 4.0 ng/ml
    Abbar, M.
    Janane, A.
    Ismail, Ould T.
    Ghadouane, M.
    Ameur, A.
    UROLOGY, 2012, 80 (03) : S295 - S295
  • [23] PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml
    Djavan, B
    Zlotta, A
    Kratzik, C
    Remzi, M
    Seitz, C
    Schulman, CC
    Marberger, M
    UROLOGY, 1999, 54 (03) : 517 - 522
  • [24] Is free/total PSA predictive of pathological stage and Gleason score in patients with prostate cancer and serum PSA ≤10 ng/ml?
    Pepe, P
    Panella, P
    Pietropaolo, F
    Pennisi, M
    Allegro, R
    Aragona, F
    UROLOGIA INTERNATIONALIS, 2006, 76 (03) : 232 - 235
  • [25] Diagnostic utility of total PSA, free PSA and PSA density at total serum PSA levels below 4 ng/ml compared to total serum PSA levels between 4.1 and 10.0 ng/ml in an early prostate cancer detection programme
    Berger, A
    Pelzer, A
    Niescher, M
    Rogatsch, H
    Klocker, H
    Bartsch, G
    Horninger, W
    JOURNAL OF UROLOGY, 2003, 169 (04): : 277 - 277
  • [26] Accuracy of percent free PSA to predict prostate cancer diagnosis in men with total PSA ranges lower than 2.5 ng/ml
    Haese, A.
    Walz, J.
    Gallina, A.
    Steuber, T.
    Briganti, A.
    Chun, F.
    Graefen, M.
    Montorsi, F.
    Huland, H.
    Karakiewicz, P. I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 50 - 50
  • [27] Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men
    Stephan, Carsten
    Xu, Chuanliang
    Cammann, Henning
    Graefen, Markus
    Haese, Alexander
    Huland, Hartwig
    Semjonow, Axel
    Diamandis, Eleftherios P.
    Remzi, Mesut
    Djavan, Bob
    Wildhagen, Mark F.
    Blijenberg, Bert G.
    Finne, Patrik
    Stenman, Ulf-Hakan
    Jung, Klaus
    Meyer, Hellmuth-Alexander
    WORLD JOURNAL OF UROLOGY, 2007, 25 (01) : 95 - 103
  • [28] Complexed PSA for early detection of prostate cancer in men with serum PSA values of 2-4 ng/mL.
    Cheli, CD
    Horninger, W
    Babaian, R
    Fritsche, H
    Taneja, S
    Lepor, H
    Sokoll, L
    Chan, D
    Childs, S
    CLINICAL CHEMISTRY, 2002, 48 (06) : A15 - A15
  • [29] Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements
    Catalona, WJ
    Smith, DS
    Ornstein, DK
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1452 - 1455
  • [30] Diagnostic value of microRNAs in prostate cancer patients with prostate specific antigen (PSA) levels between 2, and 10 ng/mL
    Akbayir, Serin
    Muslu, Necati
    Erden, Sema
    Bozlu, Murat
    TURKISH JOURNAL OF UROLOGY, 2016, 42 (04): : 247 - 255